EMERGENT BIOSOLUTIONS INC. (EBS) Operating margin 2016–2025
EMERGENT BIOSOLUTIONS INC. (EBS) operating margin by fiscal year — reported operating income divided by reported revenue.
13.5%FY2025 · since FY2016: 21.6% → 13.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 13.5% | +23.9 pp |
| FY2024 | -10.4% | +58.8 pp |
| FY2023 | -69.2% | -54.0 pp |
| FY2022 | -15.2% | -34.5 pp |
| FY2021 | 19.2% | -8.9 pp |
| FY2020 | 28.2% | +17.9 pp |
| FY2019 | 10.3% | -1.2 pp |
| FY2018 | 11.5% | -10.7 pp |
| FY2017 | 22.2% | +0.6 pp |
| FY2016 | 21.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice